• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.

作者信息

Watt F, Martorana A, Brookes D E, Ho T, Kingsley E, O'Keefe D S, Russell P J, Heston W D, Molloy P L

机构信息

CSIRO Molecular Science, North Ryde, New South Wales, 2113, Australia

出版信息

Genomics. 2001 May 1;73(3):243-54. doi: 10.1006/geno.2000.6446.

DOI:10.1006/geno.2000.6446
PMID:11350116
Abstract

Prostate-specific membrane antigen (PSMA) is an integral membrane protein that is highly expressed on the surface of prostate epithelial cells. It is also expressed on the vascular endothelium of a number of tumor types. We have used an enhancer trap approach with randomly cleaved overlapping DNA fragments from an approximately 55-kb P1 cosmid insert encompassing the 5' half and upstream sequences of the PSMA gene (FOLH1) to isolate an enhancer that strongly activates the FOLH1 core promoter region. The enhancer (PSME) is located in the third intron about 12 kb downstream from the start site of transcription and is characterized by a 72-bp direct repeat within a 331-bp core region. The PSME activates transcription from its own and heterologous promoters in prostate cell lines; enhancement is greatest in the PSMA-expressing cell line LNCaP (>250-fold). The PSME shows essentially no activity in five nonprostate cell lines. PSME-enhanced expression is repressed in the presence of androgen, mimicking the repression of the endogenous FOLH1 gene. The data demonstrate that both cell-type specificity and androgen regulation are intrinsic properties of the enhancer. These properties make the PSME an excellent candidate for regulation of gene expression in gene therapy approaches to prostate cancer.

摘要

相似文献

1
A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.
Genomics. 2001 May 1;73(3):243-54. doi: 10.1006/geno.2000.6446.
2
Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer.一种增强子对前列腺特异性膜抗原/叶酸水解酶转录的上调作用。
Gene. 2002 Feb 20;285(1-2):247-56. doi: 10.1016/s0378-1119(02)00397-9.
3
NFATc1 with AP-3 site binding specificity mediates gene expression of prostate-specific-membrane-antigen.具有AP-3位点结合特异性的NFATc1介导前列腺特异性膜抗原的基因表达。
J Mol Biol. 2003 Jul 18;330(4):749-60. doi: 10.1016/s0022-2836(03)00640-5.
4
Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.使用前列腺特异性膜抗原启动子和增强子的前列腺特异性自杀基因疗法。
Prostate. 2000 Oct 1;45(2):149-57. doi: 10.1002/1097-0045(20001001)45:2<149::aid-pros9>3.0.co;2-o.
5
An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.远上游增强子区域中的雄激素反应元件对于前列腺特异性抗原启动子的高雄激素调节活性至关重要。
Mol Endocrinol. 1997 Feb;11(2):148-61. doi: 10.1210/mend.11.2.9883.
6
Sox7 negatively regulates prostate-specific membrane antigen (PSMA) expression through PSMA-enhancer.Sox7 通过 PSMA 增强子负调控前列腺特异性膜抗原 (PSMA) 的表达。
Prostate. 2019 Mar;79(4):370-378. doi: 10.1002/pros.23743. Epub 2018 Nov 28.
7
Novel prostate-specific promoter derived from PSA and PSMA enhancers.源自前列腺特异性抗原(PSA)和前列腺特异性膜抗原(PSMA)增强子的新型前列腺特异性启动子。
Mol Ther. 2002 Sep;6(3):415-21. doi: 10.1006/mthe.2002.0682.
8
Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.在人类前列腺癌模型中,雄激素对恶性生长的反应性与前列腺特异性分化标志物前列腺特异性抗原(PSA)、人激肽释放酶2(hK2)和前列腺特异性膜抗原(PSMA)表达之间的解离。
Prostate. 2003 Mar 1;54(4):249-57. doi: 10.1002/pros.10199.
9
Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.
Mamm Genome. 2001 Feb;12(2):117-23. doi: 10.1007/s003350010240.
10
Development of gene therapy using prostate-specific membrane antigen promoter/enhancer with Cre Recombinase/LoxP system for prostate cancer cells under androgen ablation condition.在雄激素去除条件下,利用前列腺特异性膜抗原启动子/增强子与Cre重组酶/LoxP系统开发用于前列腺癌细胞的基因疗法。
Jpn J Cancer Res. 2002 Oct;93(10):1154-63. doi: 10.1111/j.1349-7006.2002.tb01218.x.

引用本文的文献

1
Androgen receptor as a potential therapeutic target in castration-resistant prostate cancer: a bibliometric analysis (2005-2024).雄激素受体作为去势抵抗性前列腺癌的潜在治疗靶点:一项文献计量分析(2005 - 2024年)
Discov Oncol. 2025 Jul 30;16(1):1441. doi: 10.1007/s12672-025-03304-6.
2
From conventional therapy to novel nano-based approaches. A focus on prostate cancer.从传统疗法到新型纳米基方法。聚焦前列腺癌。
Nanomedicine (Lond). 2025 Jun;20(11):1355-1372. doi: 10.1080/17435889.2025.2501513. Epub 2025 May 7.
3
Prostate-Specific Membrane Antigen Biology and Pathophysiology in Prostate Carcinoma, an Update: Potential Implications for Targeted Imaging and Therapy.
前列腺特异性膜抗原在前列腺癌中的生物学和病理生理学:更新:对靶向成像和治疗的潜在影响。
Int J Mol Sci. 2024 Sep 9;25(17):9755. doi: 10.3390/ijms25179755.
4
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer.前列腺癌中前列腺特异性膜抗原(PSMA)表达、调控及异质性的生物学决定因素
Nat Rev Urol. 2025 Jan;22(1):26-45. doi: 10.1038/s41585-024-00900-z. Epub 2024 Jul 8.
5
Prostate Specific Membrane Antigen Expression in a Syngeneic Breast Cancer Mouse Model.前列腺特异性膜抗原在同基因乳腺癌小鼠模型中的表达。
Mol Imaging Biol. 2024 Aug;26(4):714-728. doi: 10.1007/s11307-024-01920-2. Epub 2024 May 17.
6
From biology to the clinic - exploring liver metastasis in prostate cancer.从生物学到临床 - 探索前列腺癌中的肝转移。
Nat Rev Urol. 2024 Oct;21(10):593-614. doi: 10.1038/s41585-024-00875-x. Epub 2024 Apr 26.
7
Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer-Combination Strategies.提高 PSMA 靶向放射性核素疗法治疗晚期前列腺癌疗效的策略——联合策略。
Curr Oncol Rep. 2023 Nov;25(11):1363-1374. doi: 10.1007/s11912-023-01458-6. Epub 2023 Oct 20.
8
Up-Regulation of PSMA Expression In Vitro as Potential Application in Prostate Cancer Therapy.前列腺特异性膜抗原(PSMA)体外表达上调在前列腺癌治疗中的潜在应用
Pharmaceuticals (Basel). 2023 Apr 4;16(4):538. doi: 10.3390/ph16040538.
9
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer.雄激素受体阳性和雄激素受体阴性转移性前列腺癌中前列腺特异性膜抗原异质性和调控的全景。
Nat Cancer. 2023 May;4(5):699-715. doi: 10.1038/s43018-023-00539-6. Epub 2023 Apr 10.
10
Secreted phosphoprotein 1 promotes angiogenesis of glioblastoma through upregulating PSMA expression via transcription factor HIF1α.分泌磷蛋白 1 通过转录因子 HIF1α 上调 PSMA 表达促进脑胶质母细胞瘤血管生成。
Acta Biochim Biophys Sin (Shanghai). 2022 Oct 25;55(3):417-425. doi: 10.3724/abbs.2022157.